nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—BCHE—Irinotecan—pancreatic cancer	0.111	1	CbGbCtD
Aclidinium—Osteoarthritis—Tamoxifen—pancreatic cancer	0.00691	0.0203	CcSEcCtD
Aclidinium—Cardiac failure—Sunitinib—pancreatic cancer	0.00606	0.0178	CcSEcCtD
Aclidinium—Nasopharyngitis—Sunitinib—pancreatic cancer	0.00529	0.0155	CcSEcCtD
Aclidinium—Infestation NOS—Erlotinib—pancreatic cancer	0.00527	0.0155	CcSEcCtD
Aclidinium—Infestation—Erlotinib—pancreatic cancer	0.00527	0.0155	CcSEcCtD
Aclidinium—Sinusitis—Tamoxifen—pancreatic cancer	0.00499	0.0147	CcSEcCtD
Aclidinium—Osteoarthritis—Irinotecan—pancreatic cancer	0.00487	0.0143	CcSEcCtD
Aclidinium—Cardiac failure—Gemcitabine—pancreatic cancer	0.00486	0.0143	CcSEcCtD
Aclidinium—Cardiac failure—Fluorouracil—pancreatic cancer	0.00478	0.014	CcSEcCtD
Aclidinium—Urinary tract disorder—Erlotinib—pancreatic cancer	0.00467	0.0137	CcSEcCtD
Aclidinium—Osteoarthritis—Fluorouracil—pancreatic cancer	0.00467	0.0137	CcSEcCtD
Aclidinium—Urethral disorder—Erlotinib—pancreatic cancer	0.00463	0.0136	CcSEcCtD
Aclidinium—Infestation NOS—Sunitinib—pancreatic cancer	0.00456	0.0134	CcSEcCtD
Aclidinium—Infestation—Sunitinib—pancreatic cancer	0.00456	0.0134	CcSEcCtD
Aclidinium—Eye disorder—Erlotinib—pancreatic cancer	0.00442	0.013	CcSEcCtD
Aclidinium—Mediastinal disorder—Erlotinib—pancreatic cancer	0.00426	0.0125	CcSEcCtD
Aclidinium—Nasopharyngitis—Fluorouracil—pancreatic cancer	0.00417	0.0122	CcSEcCtD
Aclidinium—Urinary tract disorder—Sunitinib—pancreatic cancer	0.00404	0.0119	CcSEcCtD
Aclidinium—Urethral disorder—Sunitinib—pancreatic cancer	0.00401	0.0118	CcSEcCtD
Aclidinium—Eye disorder—Sunitinib—pancreatic cancer	0.00382	0.0112	CcSEcCtD
Aclidinium—Dysphonia—Epirubicin—pancreatic cancer	0.0038	0.0112	CcSEcCtD
Aclidinium—Mediastinal disorder—Sunitinib—pancreatic cancer	0.00369	0.0108	CcSEcCtD
Aclidinium—Cough—Tamoxifen—pancreatic cancer	0.00363	0.0107	CcSEcCtD
Aclidinium—Infestation—Fluorouracil—pancreatic cancer	0.0036	0.0106	CcSEcCtD
Aclidinium—Infestation NOS—Fluorouracil—pancreatic cancer	0.0036	0.0106	CcSEcCtD
Aclidinium—Cough—Erlotinib—pancreatic cancer	0.00359	0.0105	CcSEcCtD
Aclidinium—Dysphonia—Doxorubicin—pancreatic cancer	0.00352	0.0103	CcSEcCtD
Aclidinium—Dry mouth—Tamoxifen—pancreatic cancer	0.00346	0.0102	CcSEcCtD
Aclidinium—Cardiac failure—Docetaxel—pancreatic cancer	0.00345	0.0101	CcSEcCtD
Aclidinium—Rhinitis—Irinotecan—pancreatic cancer	0.00338	0.00992	CcSEcCtD
Aclidinium—Sinusitis—Fluorouracil—pancreatic cancer	0.00337	0.0099	CcSEcCtD
Aclidinium—Infection—Tamoxifen—pancreatic cancer	0.00337	0.0099	CcSEcCtD
Aclidinium—Infection—Erlotinib—pancreatic cancer	0.00334	0.00979	CcSEcCtD
Aclidinium—Nervous system disorder—Erlotinib—pancreatic cancer	0.00329	0.00967	CcSEcCtD
Aclidinium—Rhinitis—Gemcitabine—pancreatic cancer	0.00329	0.00966	CcSEcCtD
Aclidinium—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.00324	0.00952	CcSEcCtD
Aclidinium—Rhinitis—Fluorouracil—pancreatic cancer	0.00324	0.0095	CcSEcCtD
Aclidinium—Urethral disorder—Gemcitabine—pancreatic cancer	0.00322	0.00945	CcSEcCtD
Aclidinium—Cough—Sunitinib—pancreatic cancer	0.00311	0.00912	CcSEcCtD
Aclidinium—Mediastinal disorder—Irinotecan—pancreatic cancer	0.00304	0.00892	CcSEcCtD
Aclidinium—Nasopharyngitis—Docetaxel—pancreatic cancer	0.00301	0.00884	CcSEcCtD
Aclidinium—Dry mouth—Sunitinib—pancreatic cancer	0.00297	0.00871	CcSEcCtD
Aclidinium—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.00296	0.00869	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00293	0.0086	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.0029	0.00851	CcSEcCtD
Aclidinium—Infection—Sunitinib—pancreatic cancer	0.00289	0.00848	CcSEcCtD
Aclidinium—Nervous system disorder—Sunitinib—pancreatic cancer	0.00285	0.00837	CcSEcCtD
Aclidinium—Vision blurred—Fluorouracil—pancreatic cancer	0.00265	0.00777	CcSEcCtD
Aclidinium—Diabetes mellitus—Epirubicin—pancreatic cancer	0.00261	0.00767	CcSEcCtD
Aclidinium—Infestation NOS—Docetaxel—pancreatic cancer	0.0026	0.00762	CcSEcCtD
Aclidinium—Infestation—Docetaxel—pancreatic cancer	0.0026	0.00762	CcSEcCtD
Aclidinium—Cough—Irinotecan—pancreatic cancer	0.00256	0.00752	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00251	0.00737	CcSEcCtD
Aclidinium—Cough—Gemcitabine—pancreatic cancer	0.00249	0.00732	CcSEcCtD
Aclidinium—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.00242	0.00709	CcSEcCtD
Aclidinium—Infection—Irinotecan—pancreatic cancer	0.00238	0.00698	CcSEcCtD
Aclidinium—Nervous system disorder—Irinotecan—pancreatic cancer	0.00235	0.00689	CcSEcCtD
Aclidinium—Rhinitis—Docetaxel—pancreatic cancer	0.00234	0.00686	CcSEcCtD
Aclidinium—Cardiac failure—Epirubicin—pancreatic cancer	0.00233	0.00683	CcSEcCtD
Aclidinium—Diarrhoea—Tamoxifen—pancreatic cancer	0.00232	0.00682	CcSEcCtD
Aclidinium—Infection—Gemcitabine—pancreatic cancer	0.00232	0.0068	CcSEcCtD
Aclidinium—Urinary tract disorder—Docetaxel—pancreatic cancer	0.0023	0.00675	CcSEcCtD
Aclidinium—Diarrhoea—Erlotinib—pancreatic cancer	0.0023	0.00675	CcSEcCtD
Aclidinium—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00229	0.00672	CcSEcCtD
Aclidinium—Urethral disorder—Docetaxel—pancreatic cancer	0.00228	0.0067	CcSEcCtD
Aclidinium—Infection—Fluorouracil—pancreatic cancer	0.00228	0.00669	CcSEcCtD
Aclidinium—Osteoarthritis—Epirubicin—pancreatic cancer	0.00227	0.00667	CcSEcCtD
Aclidinium—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00225	0.0066	CcSEcCtD
Aclidinium—Tachycardia—Fluorouracil—pancreatic cancer	0.00224	0.00657	CcSEcCtD
Aclidinium—Eye disorder—Docetaxel—pancreatic cancer	0.00218	0.00639	CcSEcCtD
Aclidinium—Vomiting—Tamoxifen—pancreatic cancer	0.00216	0.00634	CcSEcCtD
Aclidinium—Cardiac failure—Doxorubicin—pancreatic cancer	0.00215	0.00632	CcSEcCtD
Aclidinium—Vomiting—Erlotinib—pancreatic cancer	0.00214	0.00627	CcSEcCtD
Aclidinium—Headache—Tamoxifen—pancreatic cancer	0.00213	0.00624	CcSEcCtD
Aclidinium—Headache—Erlotinib—pancreatic cancer	0.0021	0.00618	CcSEcCtD
Aclidinium—Osteoarthritis—Doxorubicin—pancreatic cancer	0.0021	0.00617	CcSEcCtD
Aclidinium—Mediastinal disorder—Docetaxel—pancreatic cancer	0.0021	0.00616	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00207	0.00607	CcSEcCtD
Aclidinium—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00203	0.00596	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00201	0.00591	CcSEcCtD
Aclidinium—Diarrhoea—Sunitinib—pancreatic cancer	0.00199	0.00584	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00198	0.00581	CcSEcCtD
Aclidinium—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.00188	0.00552	CcSEcCtD
Aclidinium—Vomiting—Sunitinib—pancreatic cancer	0.00185	0.00543	CcSEcCtD
Aclidinium—Headache—Sunitinib—pancreatic cancer	0.00182	0.00535	CcSEcCtD
Aclidinium—Cough—Docetaxel—pancreatic cancer	0.00177	0.0052	CcSEcCtD
Aclidinium—Infestation NOS—Epirubicin—pancreatic cancer	0.00175	0.00514	CcSEcCtD
Aclidinium—Infestation—Epirubicin—pancreatic cancer	0.00175	0.00514	CcSEcCtD
Aclidinium—Dry mouth—Docetaxel—pancreatic cancer	0.00169	0.00496	CcSEcCtD
Aclidinium—Infection—Docetaxel—pancreatic cancer	0.00164	0.00483	CcSEcCtD
Aclidinium—Sinusitis—Epirubicin—pancreatic cancer	0.00164	0.00482	CcSEcCtD
Aclidinium—Diarrhoea—Irinotecan—pancreatic cancer	0.00164	0.00481	CcSEcCtD
Aclidinium—Nervous system disorder—Docetaxel—pancreatic cancer	0.00162	0.00477	CcSEcCtD
Aclidinium—Infestation—Doxorubicin—pancreatic cancer	0.00162	0.00476	CcSEcCtD
Aclidinium—Infestation NOS—Doxorubicin—pancreatic cancer	0.00162	0.00476	CcSEcCtD
Aclidinium—Tachycardia—Docetaxel—pancreatic cancer	0.00162	0.00474	CcSEcCtD
Aclidinium—Diarrhoea—Gemcitabine—pancreatic cancer	0.0016	0.00469	CcSEcCtD
Aclidinium—Rhinitis—Epirubicin—pancreatic cancer	0.00158	0.00463	CcSEcCtD
Aclidinium—Diarrhoea—Fluorouracil—pancreatic cancer	0.00157	0.00461	CcSEcCtD
Aclidinium—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00155	0.00456	CcSEcCtD
Aclidinium—Urethral disorder—Epirubicin—pancreatic cancer	0.00154	0.00452	CcSEcCtD
Aclidinium—Vomiting—Irinotecan—pancreatic cancer	0.00152	0.00447	CcSEcCtD
Aclidinium—Sinusitis—Doxorubicin—pancreatic cancer	0.00152	0.00446	CcSEcCtD
Aclidinium—Headache—Irinotecan—pancreatic cancer	0.0015	0.0044	CcSEcCtD
Aclidinium—Vomiting—Gemcitabine—pancreatic cancer	0.00148	0.00435	CcSEcCtD
Aclidinium—Eye disorder—Epirubicin—pancreatic cancer	0.00147	0.00431	CcSEcCtD
Aclidinium—Headache—Gemcitabine—pancreatic cancer	0.00146	0.00429	CcSEcCtD
Aclidinium—Vomiting—Fluorouracil—pancreatic cancer	0.00146	0.00428	CcSEcCtD
Aclidinium—Rhinitis—Doxorubicin—pancreatic cancer	0.00146	0.00428	CcSEcCtD
Aclidinium—Headache—Fluorouracil—pancreatic cancer	0.00144	0.00422	CcSEcCtD
Aclidinium—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00144	0.00422	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00143	0.0042	CcSEcCtD
Aclidinium—Urethral disorder—Doxorubicin—pancreatic cancer	0.00143	0.00418	CcSEcCtD
Aclidinium—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00142	0.00416	CcSEcCtD
Aclidinium—Eye disorder—Doxorubicin—pancreatic cancer	0.00136	0.00399	CcSEcCtD
Aclidinium—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.00131	0.00385	CcSEcCtD
Aclidinium—Vision blurred—Epirubicin—pancreatic cancer	0.00129	0.00378	CcSEcCtD
Aclidinium—Cough—Epirubicin—pancreatic cancer	0.00119	0.0035	CcSEcCtD
Aclidinium—Vision blurred—Doxorubicin—pancreatic cancer	0.00119	0.0035	CcSEcCtD
Aclidinium—Dry mouth—Epirubicin—pancreatic cancer	0.00114	0.00334	CcSEcCtD
Aclidinium—Diarrhoea—Docetaxel—pancreatic cancer	0.00113	0.00332	CcSEcCtD
Aclidinium—Infection—Epirubicin—pancreatic cancer	0.00111	0.00326	CcSEcCtD
Aclidinium—Cough—Doxorubicin—pancreatic cancer	0.0011	0.00324	CcSEcCtD
Aclidinium—Nervous system disorder—Epirubicin—pancreatic cancer	0.00109	0.00321	CcSEcCtD
Aclidinium—Tachycardia—Epirubicin—pancreatic cancer	0.00109	0.0032	CcSEcCtD
Aclidinium—Dry mouth—Doxorubicin—pancreatic cancer	0.00105	0.00309	CcSEcCtD
Aclidinium—Vomiting—Docetaxel—pancreatic cancer	0.00105	0.00309	CcSEcCtD
Aclidinium—Headache—Docetaxel—pancreatic cancer	0.00104	0.00304	CcSEcCtD
Aclidinium—Infection—Doxorubicin—pancreatic cancer	0.00103	0.00301	CcSEcCtD
Aclidinium—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00101	0.00297	CcSEcCtD
Aclidinium—Tachycardia—Doxorubicin—pancreatic cancer	0.00101	0.00296	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000964	0.00283	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000892	0.00262	CcSEcCtD
Aclidinium—Diarrhoea—Epirubicin—pancreatic cancer	0.000764	0.00224	CcSEcCtD
Aclidinium—Vomiting—Epirubicin—pancreatic cancer	0.00071	0.00208	CcSEcCtD
Aclidinium—Diarrhoea—Doxorubicin—pancreatic cancer	0.000707	0.00208	CcSEcCtD
Aclidinium—Headache—Epirubicin—pancreatic cancer	0.000699	0.00205	CcSEcCtD
Aclidinium—Vomiting—Doxorubicin—pancreatic cancer	0.000657	0.00193	CcSEcCtD
Aclidinium—Headache—Doxorubicin—pancreatic cancer	0.000647	0.0019	CcSEcCtD
Aclidinium—CHRM1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000128	0.000233	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000128	0.000233	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	0.000128	0.000232	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	0.000127	0.000231	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000126	0.00023	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CXCL8—pancreatic cancer	0.000123	0.000224	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TERT—pancreatic cancer	0.000122	0.000223	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CNR1—pancreatic cancer	0.000121	0.000221	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	0.000121	0.00022	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	0.00012	0.000218	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—APOE—pancreatic cancer	0.000119	0.000218	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000118	0.000214	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000117	0.000214	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TERT—pancreatic cancer	0.000117	0.000213	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—GCG—pancreatic cancer	0.000117	0.000213	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HIF1A—pancreatic cancer	0.000117	0.000213	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TSC2—pancreatic cancer	0.000117	0.000213	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—GCG—pancreatic cancer	0.000117	0.000213	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000116	0.000212	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—GCG—pancreatic cancer	0.000116	0.000211	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—APOE—pancreatic cancer	0.000114	0.000208	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000114	0.000208	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000114	0.000207	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	0.000113	0.000206	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—TYMS—pancreatic cancer	0.000113	0.000206	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000112	0.000205	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HIF1A—pancreatic cancer	0.000112	0.000204	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—KDR—pancreatic cancer	0.000112	0.000204	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TSC2—pancreatic cancer	0.000112	0.000204	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	0.000112	0.000203	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	0.000111	0.000203	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	0.00011	0.000201	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—STK11—pancreatic cancer	0.00011	0.000201	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—STK11—pancreatic cancer	0.00011	0.0002	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—APOE—pancreatic cancer	0.000109	0.000199	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—STK11—pancreatic cancer	0.000109	0.000198	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PIK3CG—pancreatic cancer	0.000108	0.000196	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—KDR—pancreatic cancer	0.000107	0.000195	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NFKBIA—pancreatic cancer	0.000106	0.000194	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NOTCH1—pancreatic cancer	0.000105	0.000192	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PPARG—pancreatic cancer	0.000104	0.000189	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000103	0.000188	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000103	0.000188	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PIK3CG—pancreatic cancer	0.000103	0.000188	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—NRAS—pancreatic cancer	0.000103	0.000188	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000102	0.000186	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NFKBIA—pancreatic cancer	0.000102	0.000186	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—EGF—pancreatic cancer	0.000102	0.000186	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NOTCH1—pancreatic cancer	0.000101	0.000184	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.93e-05	0.000181	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.89e-05	0.00018	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PIK3CG—pancreatic cancer	9.87e-05	0.00018	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—NRAS—pancreatic cancer	9.87e-05	0.00018	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.8e-05	0.000179	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—EGF—pancreatic cancer	9.76e-05	0.000178	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	9.64e-05	0.000176	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	9.61e-05	0.000175	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	9.54e-05	0.000174	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	9.52e-05	0.000173	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	9.51e-05	0.000173	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PIK3CD—pancreatic cancer	9.47e-05	0.000173	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	9.42e-05	0.000172	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HES1—pancreatic cancer	9.41e-05	0.000172	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—EGFR—pancreatic cancer	9.39e-05	0.000171	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HES1—pancreatic cancer	9.38e-05	0.000171	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HES1—pancreatic cancer	9.29e-05	0.000169	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—APOE—pancreatic cancer	9.18e-05	0.000167	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PIK3CD—pancreatic cancer	9.06e-05	0.000165	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	9.01e-05	0.000164	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—EGFR—pancreatic cancer	8.99e-05	0.000164	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	8.99e-05	0.000164	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.97e-05	0.000164	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	8.9e-05	0.000162	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—KRAS—pancreatic cancer	8.87e-05	0.000162	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PIK3CD—pancreatic cancer	8.68e-05	0.000158	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	8.66e-05	0.000158	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	8.63e-05	0.000157	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.59e-05	0.000157	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	8.55e-05	0.000156	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—KRAS—pancreatic cancer	8.49e-05	0.000155	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PIK3CG—pancreatic cancer	8.28e-05	0.000151	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PIK3CB—pancreatic cancer	8.26e-05	0.00015	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TERT—pancreatic cancer	8.25e-05	0.00015	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TERT—pancreatic cancer	8.22e-05	0.00015	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PTGS2—pancreatic cancer	8.18e-05	0.000149	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—PIK3CA—pancreatic cancer	8.15e-05	0.000148	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TERT—pancreatic cancer	8.14e-05	0.000148	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PPARG—pancreatic cancer	8e-05	0.000146	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PIK3CB—pancreatic cancer	7.9e-05	0.000144	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	7.89e-05	0.000144	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	7.87e-05	0.000143	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	7.86e-05	0.000143	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	7.84e-05	0.000143	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—PIK3CA—pancreatic cancer	7.8e-05	0.000142	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	7.79e-05	0.000142	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	7.77e-05	0.000142	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—APOE—pancreatic cancer	7.7e-05	0.00014	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—APOE—pancreatic cancer	7.68e-05	0.00014	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—APOE—pancreatic cancer	7.6e-05	0.000139	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CXCL8—pancreatic cancer	7.59e-05	0.000138	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PIK3CB—pancreatic cancer	7.56e-05	0.000138	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—KDR—pancreatic cancer	7.54e-05	0.000137	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—HRAS—pancreatic cancer	7.54e-05	0.000137	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—KDR—pancreatic cancer	7.52e-05	0.000137	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—KDR—pancreatic cancer	7.45e-05	0.000136	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—AKT1—pancreatic cancer	7.33e-05	0.000134	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PIK3CD—pancreatic cancer	7.28e-05	0.000133	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CXCL8—pancreatic cancer	7.27e-05	0.000132	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CASP3—pancreatic cancer	7.26e-05	0.000132	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—HRAS—pancreatic cancer	7.22e-05	0.000132	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	7.18e-05	0.000131	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	7.15e-05	0.00013	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PTEN—pancreatic cancer	7.13e-05	0.00013	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	7.11e-05	0.000129	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	7.08e-05	0.000129	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	7.08e-05	0.000129	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCND1—pancreatic cancer	7.07e-05	0.000129	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—AKT1—pancreatic cancer	7.02e-05	0.000128	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	7.01e-05	0.000128	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CTNNB1—pancreatic cancer	7e-05	0.000128	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CASP3—pancreatic cancer	6.96e-05	0.000127	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	6.95e-05	0.000127	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	6.95e-05	0.000127	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	6.93e-05	0.000126	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	6.93e-05	0.000126	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—EGF—pancreatic cancer	6.87e-05	0.000125	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MMP9—pancreatic cancer	6.86e-05	0.000125	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	6.86e-05	0.000125	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	6.86e-05	0.000125	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—EGF—pancreatic cancer	6.85e-05	0.000125	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PTEN—pancreatic cancer	6.82e-05	0.000124	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—EGF—pancreatic cancer	6.78e-05	0.000124	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCND1—pancreatic cancer	6.77e-05	0.000123	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CTNNB1—pancreatic cancer	6.7e-05	0.000122	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—AKT1—pancreatic cancer	6.66e-05	0.000121	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MMP9—pancreatic cancer	6.57e-05	0.00012	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PTEN—pancreatic cancer	6.53e-05	0.000119	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—AKT1—pancreatic cancer	6.38e-05	0.000116	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PIK3CB—pancreatic cancer	6.35e-05	0.000116	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	6.33e-05	0.000115	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—SRC—pancreatic cancer	6.33e-05	0.000115	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	6.31e-05	0.000115	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PTGS2—pancreatic cancer	6.29e-05	0.000115	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	6.25e-05	0.000114	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—VEGFA—pancreatic cancer	6.16e-05	0.000112	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	6.11e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—STAT3—pancreatic cancer	6.1e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	6.09e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NRAS—pancreatic cancer	6.09e-05	0.000111	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—SRC—pancreatic cancer	6.06e-05	0.00011	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.05e-05	0.00011	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.03e-05	0.00011	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	6.03e-05	0.00011	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	5.98e-05	0.000109	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.97e-05	0.000109	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	5.96e-05	0.000109	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	5.9e-05	0.000108	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—VEGFA—pancreatic cancer	5.9e-05	0.000108	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—STAT3—pancreatic cancer	5.84e-05	0.000106	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NRAS—pancreatic cancer	5.83e-05	0.000106	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MYC—pancreatic cancer	5.67e-05	0.000103	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TGFB1—pancreatic cancer	5.66e-05	0.000103	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—EGFR—pancreatic cancer	5.55e-05	0.000101	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	5.49e-05	0.0001	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PTEN—pancreatic cancer	5.49e-05	9.99e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	5.48e-05	9.98e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MYC—pancreatic cancer	5.43e-05	9.9e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	5.42e-05	9.88e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TGFB1—pancreatic cancer	5.42e-05	9.87e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	5.32e-05	9.7e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—EGFR—pancreatic cancer	5.31e-05	9.68e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	5.31e-05	9.67e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	5.26e-05	9.58e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—KRAS—pancreatic cancer	5.24e-05	9.55e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	5.12e-05	9.32e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	5.1e-05	9.29e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	5.08e-05	9.26e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	5.07e-05	9.23e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	5.05e-05	9.2e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PIK3CA—pancreatic cancer	5.03e-05	9.17e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	5.02e-05	9.14e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—KRAS—pancreatic cancer	5.02e-05	9.14e-05	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	4.94e-05	9.01e-05	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	4.93e-05	8.98e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	4.9e-05	8.92e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	4.88e-05	8.9e-05	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	4.88e-05	8.89e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	4.83e-05	8.81e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—PIK3CA—pancreatic cancer	4.81e-05	8.77e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	4.77e-05	8.69e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	4.75e-05	8.66e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	4.72e-05	8.6e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	4.71e-05	8.57e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	4.71e-05	8.57e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	4.66e-05	8.49e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TP53—pancreatic cancer	4.66e-05	8.49e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	4.63e-05	8.43e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	4.61e-05	8.41e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	4.61e-05	8.4e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	4.6e-05	8.38e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	4.59e-05	8.36e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	4.57e-05	8.32e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	4.54e-05	8.28e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	4.49e-05	8.18e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	4.47e-05	8.15e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TP53—pancreatic cancer	4.46e-05	8.13e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	4.45e-05	8.12e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	4.43e-05	8.07e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—SRC—pancreatic cancer	4.27e-05	7.78e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	4.27e-05	7.77e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—SRC—pancreatic cancer	4.25e-05	7.75e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—SRC—pancreatic cancer	4.21e-05	7.68e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	4.16e-05	7.57e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	4.14e-05	7.55e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	4.12e-05	7.5e-05	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—AKT1—pancreatic cancer	4.11e-05	7.49e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	4.11e-05	7.48e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	4.1e-05	7.48e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	4.1e-05	7.47e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	4.09e-05	7.46e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	4.06e-05	7.4e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	4.05e-05	7.38e-05	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	3.93e-05	7.17e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PIK3CA—pancreatic cancer	3.87e-05	7.05e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MYC—pancreatic cancer	3.82e-05	6.97e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	3.81e-05	6.95e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MYC—pancreatic cancer	3.81e-05	6.95e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	3.8e-05	6.93e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MYC—pancreatic cancer	3.77e-05	6.88e-05	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	3.77e-05	6.86e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	3.77e-05	6.86e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	3.74e-05	6.81e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	3.73e-05	6.79e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	3.69e-05	6.73e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	3.53e-05	6.44e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	3.52e-05	6.42e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	3.49e-05	6.36e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	3.25e-05	5.91e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	3.24e-05	5.9e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	3.2e-05	5.84e-05	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—AKT1—pancreatic cancer	3.16e-05	5.76e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TP53—pancreatic cancer	3.14e-05	5.72e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TP53—pancreatic cancer	3.13e-05	5.7e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TP53—pancreatic cancer	3.1e-05	5.65e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	3e-05	5.47e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	2.99e-05	5.45e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	2.96e-05	5.4e-05	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	2.65e-05	4.83e-05	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	2.64e-05	4.82e-05	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	2.62e-05	4.77e-05	CbGpPWpGaD
